Gal-1 (Galectin-1) Upregulation Contributes to Abdominal Aortic Aneurysm Progression by Enhancing Vascular Inflammation
暂无分享,去创建一个
Jaw-Wen Chen | H. Leu | Fu-Tong Liu | I. Chen | M. Tsai | F. Hsu | L. Chau | Po‐Hsun Huang | Yen-Hui Chen | Y. Hsu | Ying-Hwa Chen | Ming-Tsai Chiang | Jaw-wen Chen | Fu-Fei Hsu
[1] P. Wei,et al. Galectin-1 Restricts Vascular Smooth Muscle Cell Motility Via Modulating Adhesion Force and Focal Adhesion Dynamics , 2018, Scientific Reports.
[2] M. Fijak,et al. Galectin-1 enhances TNFα-induced inflammatory responses in Sertoli cells through activation of MAPK signalling , 2018, Scientific Reports.
[3] G. Rabinovich,et al. Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation , 2017, Journal of Immunology.
[4] J. Raffort,et al. Monocytes and macrophages in abdominal aortic aneurysm , 2017, Nature Reviews Cardiology.
[5] Y. Hu,et al. ERK5 kinase activity is dispensable for cellular immune response and proliferation , 2016, Proceedings of the National Academy of Sciences.
[6] I. Peshkova,et al. Atherosclerosis and aortic aneurysm – is inflammation a common denominator? , 2016, The FEBS journal.
[7] K. Kent,et al. Clinical practice. Abdominal aortic aneurysms. , 2014, The New England journal of medicine.
[8] G. Rabinovich,et al. Structural basis of redox-dependent modulation of galectin-1 dynamics and function. , 2014, Glycobiology.
[9] P. Tsao,et al. Pathogenesis of abdominal aortic aneurysms: microRNAs, proteases, genetic associations. , 2014, Annual review of medicine.
[10] G. Rabinovich,et al. Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. , 2013, The American journal of pathology.
[11] D. Morrison,et al. MAP kinase pathways. , 2012, Cold Spring Harbor perspectives in biology.
[12] Qingbo Xu,et al. Hyperhomocysteinemia Exaggerates Adventitial Inflammation and Angiotensin II−Induced Abdominal Aortic Aneurysm in Mice , 2012, Circulation research.
[13] C. Bhamidipati,et al. Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. , 2011, The Journal of thoracic and cardiovascular surgery.
[14] H. Inoue,et al. Activation of RAW264.7 macrophages by oxidized galectin-1. , 2010, Immunology letters.
[15] J. Golledge,et al. Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[16] U. Piomelli,et al. The Murine Angiotensin II-Induced Abdominal Aortic Aneurysm Model: Rupture Risk and Inflammatory Progression Patterns , 2010, Front. Pharm..
[17] Gani Bajraktari,et al. Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[18] D. Milewicz,et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. , 2009, The Journal of clinical investigation.
[19] J. Mactaggart,et al. Blocking TNF-α Attenuates Aneurysm Formation in a Murine Model1 , 2009, The Journal of Immunology.
[20] J. Carstensen,et al. Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population , 2008, PloS one.
[21] Masaaki Ito,et al. Big Mitogen-Activated Protein Kinase: A New Player in Vascular Remodeling , 2007, Hypertension Research.
[22] J. Harral,et al. Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[23] R. Kiss,et al. Galectin-1: a small protein with major functions. , 2006, Glycobiology.
[24] Ruud P. M. Dings,et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy , 2006, Proceedings of the National Academy of Sciences.
[25] R. Charnigo,et al. Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography. , 2006, Journal of vascular surgery.
[26] J. Lindholt,et al. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[27] Peter Libby,et al. Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[28] Kyung-Chan Kim,et al. MAP Kinase activation is required for the MMP-9 induction by TNF-stimulation , 2005, Archives of pharmacal research.
[29] D. Kass,et al. p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart , 2005, Circulation.
[30] K. Sunagawa,et al. Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[31] T. Masuda,et al. Expression and localization of tumour necrosis factor-α and its converting enzyme in human abdominal aortic aneurysm , 2004 .
[32] N. Hikawa,et al. Oxidized Galectin-1 Stimulates Macrophages to Promote Axonal Regeneration in Peripheral Nerves after Axotomy , 2004, The Journal of Neuroscience.
[33] A. Daugherty,et al. Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[34] F. Cambien,et al. Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease , 2003, Circulation.
[35] Y. Kloog,et al. Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.
[36] John L. Wang,et al. Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.
[37] Stefano Iacobelli,et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.
[38] Y. Kloog,et al. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation , 2001, Oncogene.
[39] A. Cho,et al. Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[40] J. Hedges,et al. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. , 2000, American journal of respiratory cell and molecular biology.
[41] H. Horie,et al. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. , 2000, European journal of biochemistry.
[42] Q. Javed,et al. Galectin 1 is involved in vascular smooth muscle cell proliferation. , 2000, Cardiovascular research.
[43] G. Hunninghake,et al. Both Erk and p38 kinases are necessary for cytokine gene transcription. , 1999, American journal of respiratory cell and molecular biology.
[44] E. P. Moiseeva,et al. Galectin 1 Modulates Attachment, Spreading and Migration of Cultured Vascular Smooth Muscle Cells via Interactions with Cellular Receptors and Components ofExtracellu lar Matrix , 1999, Journal of Vascular Research.
[45] R. Carruthers,et al. Subunit molecular mass assignment of 14,654 Da to the soluble beta-galactoside-binding lectin from bovine heart muscle and demonstration of intramolecular disulfide bonding associated with oxidative inactivation. , 1992, The Journal of biological chemistry.
[46] S. Barondes,et al. Soluble lectins: a new class of extracellular proteins. , 1984, Science.